Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival-Reference-Cited by-同舟云学术

Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival

Published:2015-01 Issue:1 Volume:261 Page:164-171
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Seeberg Lars Thomas,Waage Anne,Brunborg Cathrine,Hugenschmidt Harald,Renolen Anne,Stav Ingun,Bjørnbeth Bjørn Atle,Brudvik Kristoffer W.,Borgen Elin F.,Naume Bjørn,Wiedswang Gro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference26 articles.

1. Epidemiology and management of liver metastases from colorectal cancer.;Manfredi;Ann Surg,2006

2. Treatment advances in liver-limited metastatic colorectal cancer.;Alberts;Clin Colorectal Cancer,2011

3. Improving response and outcomes for patients with liver-limited metastatic colorectal cancer.;Gallagher;Clin Colorectal Cancer,2010

4. Evaluation of long-time survival after hepatic resection for metastatic colorectal cancer.;Rees;Ann Surg,2008

5. Validation of prognostic scoring systems for patients undergoing resection of colorectal liver metastases.;Reissfelder;Ann Surg Onc,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases;Clinical & Experimental Metastasis;2022-11-03

2. Meta-analysis of the prognostic value of circulating tumor cells in gastrointestinal cancer;Medicine;2022-10-21

3. Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical Utility;Cancers;2022-10-06

4. Prognostic factors in colorectal liver metastases patients with various tumor numbers treated by liver resection: a single-center, retrospective study;World Journal of Surgical Oncology;2022-07-20

5. Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases;BMC Cancer;2022-06-16